Skip to main content

Advertisement

Log in

Palladium complexes: new candidates for anti-cancer drugs

  • Review
  • Published:
Journal of the Iranian Chemical Society Aims and scope Submit manuscript

Abstract

Platinum complexes which are most studied metal complexes due to their importance as adjuvant therapy of cancers aiming to induce tumor-cell-death. Some of the platinum-based antitumor drugs like cisplatin, carboplatin and oxaliplatin, have several disadvantages including side effects, cisplatin-resistant tumors, limited solubility in aqueous media, and so on. Thus, to achieve lower undesirable toxicity, enhanced solubility, and tumor selectivity, significant amount of work have been devoted to the preparation of modified platinum complexes. One of the ways to design the new anti-tumor agents related to cisplatin is to change the nature of central metal ion. Among the non-platinum metal complexes studied for cancer treatment, palladium(II) derivatives were readily chosen due to their structural analogy with those containing Pt(II) complexes. This review focuses on anti-tumor property of Pd(II) complexes and makes comparisons with similar property of cisplatin. Then, in the review, palladium(II) complexes have been classified according to their leaving ligands into palladium(II) complexes. In the last part, the most important factors affecting on the anti-tumor activity of the Pd(II) complexes were discussed. These factors are encouraging more researches in this field, for future applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. M. Shaharyar, M.M. Abdullah, M.A. Bakht, J. Majeed, Pyrazoline bearing benzimidazoles: search for anticancer agent. Eur. J. Med. Chem. 45, 114 (2010)

    Article  CAS  Google Scholar 

  2. H. Khan, A. Badshah, G. Murtaz, M. Said, Z.U. Rehman, C. Neuhausen, M. Todorova, B.J. Jean-Claude, I.S. Butler, Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium(II) complexes. Eur. J. Med. Chem. 46, 4071 (2011)

    Article  CAS  Google Scholar 

  3. P. Christakis, The birth of chemotherapy at Yale. Yale J. Biol. Med. 84, 169 (2011)

    Google Scholar 

  4. A. Divsalar, I. Zhila, A.A. Saboury, M. Nabiuni, M. Razmi, H. Mansuri-Torshizi, Cytotoxic and spectroscopic studies on binding of a new synthesized bipyridine ethyl dithiocarbamate Pt(II) nitratecomplex to the milk carrier protein of BLG. J. Iran. Chem. Soc. 10, 951 (2013)

    Article  CAS  Google Scholar 

  5. American Cancer Society, Cancer Facts and Figures 2010 [Internet]. (American Cancer Society, Atlanta, 2010), http://www.cancer.org/acs/groups/content/@nho/documents/document/acspc-024113

  6. National Cancer Institute, Cancer trends progress report, 2009/2010. http://progressreport.cancer.gov

  7. V.T. DeVita, J.R. Chu, A history of cancer chemotherapy. Cancer Res. 68, 8643 (2008)

    Article  CAS  Google Scholar 

  8. J.H. Brested, The Edwin Smith surgical papyrus. Translated for The New York Historical Society (University of Chicago Press, Chicago, 1930)

  9. V.T. DeVita, The evolution of therapeutic research in cancer. New Eng. J. Med. 298, 907 (1978)

    Article  Google Scholar 

  10. W. Osler, The Principles and Practice of Medicine (D. Appleton and Company, New York, 1893), p. 708

    Google Scholar 

  11. R.S. Kumar, S. Arunachalam, V.S. Periasamy, C.P. Preethy, A. Riyasdeen, M.A. Akbarsha, Surfactant-cobalt(III) complexes: synthesis, critical micelle concentration (CMC) determination, DNA binding, antimicrobial and cytotoxicity studies. J. Inorg. Biochem. 103, 117 (2009)

    Article  CAS  Google Scholar 

  12. M. Shavit, D. Peri, A. Melman, E.Y. Tshuva, Antitumor reactivity of non-metallocene titanium complexes of oxygen-based ligands: is ligand lability essential? J. Biol. Inorg. Chem. 12, 825 (2007)

    Article  CAS  Google Scholar 

  13. C. Deegan, M. McCann, M. Devereux, B. Coyle, D.A. Egan, In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]·2H2O, [Cu(phen)2(mal)]·2H2O and [Mn(phen)2(mal)]·2H2O (malH2 = malonic acid) using human cancer cells. Cancer Lett. 247, 224 (2007)

    Article  CAS  Google Scholar 

  14. H. Mansouri-Torshizi, M. Saeidifar, F. Khosravi, A. Divsalar, A.A. Saboury, Z.Y. Ghasemi, DNA-binding and thermodynamic parameters, structure and cytotoxicity of newly designed platinum(II) and palladium(II) anti-tumor complexes. Bull. Korean Chem. Soc. 32, 947 (2011)

    Article  CAS  Google Scholar 

  15. M. Frezza, S. Hindo, D. Chen, A. Davenport, S. Schmitt, D. Tomco, Q.P. Dou, Novel metals and metal complexes as platforms for cancer therapy. Curr. Pharm. Des. 16, 1813 (2010)

    Article  CAS  Google Scholar 

  16. A.M. Florea, D. Büsselberg, Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3, 1351 (2011)

    Article  CAS  Google Scholar 

  17. R. Silavi, A. Divsalar, A.A. Saboury, A short review on the structure–function relationship of artificial catecholase/tyrosinase and nuclease activities of Cu-complexes. J. Biomol. Struct. Dyn. 30, 752 (2012)

    Article  CAS  Google Scholar 

  18. J. Zhang, L. Wang, Z. Xing, D. Liu, J. Sun, X. Li, Y. Zhang, Status of bi- and multi-nuclear platinum anticancer drug development. Anticancer Agents Med. Chem. 10, 272 (2010)

    Article  CAS  Google Scholar 

  19. N. Shah, D.S. Dizon, New-generation platinum agents for solid tumors. Future Oncol. 5, 33 (2009)

    Article  CAS  Google Scholar 

  20. Q. Zhang, W. Zhong, B. Xing, W. Tang, Y.J. Chen, Binding properties and stoichiometries of a palladium (II) complex to metallothioneins in vivo and in vitro. Inorg. Biochem. 72, 195 (1998)

    Article  CAS  Google Scholar 

  21. J. Kasparkova, J. Zehnulova, N. Farrel, V. Brabec, DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair. J. Biol. Chem. 277, 48076 (2002)

    Article  CAS  Google Scholar 

  22. A. Divsalar, A.A. Saboury, A.A. Moosavi-Movahedi, H. Mansoori-Torshizi, Comparative analysis of refolding of chemically denatured beta-lactoglobulin types A, B using the dilution additive mode. Int. J. Biol. Macromol. 38, 9 (2006)

    Article  CAS  Google Scholar 

  23. A. Divsalar, A.A. Saboury, H. Mansoori-Torshizi, A.A. Moosavi-Movahedi, Binding properties of a new anti-tumor component (2,2′-bipyridin octylglycinato Pd(II) nitrate) with bovine β-lactoglobulin-A and -B. J. Biomol. Struct. Dyn. 25, 0739 (2007)

    Article  Google Scholar 

  24. A. Divsalar, A.A. Saboury, R. Yousefia, A.A. Moosavi-Movahedi, H. Mansoori-Torshizi, Spectroscopic and cytotoxic studies of the novel designed palladium(II) complexes: β-lactoglobulin and K562 as the targets. Int. J. Biol. Macromol. 40, 381 (2007)

    Article  CAS  Google Scholar 

  25. H. Mansouri-Torshizi, M. Saeidifar, A. Divsalar, A.A. Saboury, Binding studies of a novel antitumor palladium (II) complex to calf thymus DNA. Nucleosides Nucleotides Nucleic Acids 30, 405 (2011)

    Article  CAS  Google Scholar 

  26. A. Divsalar, M.J. Bagheri, A.A. Saboury, H. Mansoori-Torshizi, M. Amani, Investigation on the interaction of newly designed anticancer pd(II) complexes with different aliphatic tails and human serum albumin. J. Phys. Chem. B. 113, 14035 (2009)

    Article  CAS  Google Scholar 

  27. A. Divsalar, A.A. Saboury, H. Mansoori-Torshizi, M.I. Moghaddam, F. Ahmad, G.H. Hakimelahi, Comparative studies on the interaction between bovine β-lactoglobulin Qpe A and B and a new designed Pd(I1) complex with anti-tumor activity at different temperature. J. Biomol. Struct. Dyn. 26, 587 (2009)

    Article  CAS  Google Scholar 

  28. A. Divsalar, A.A. Saboury, L. Ahadi, E. Zemanatiyar, H. Mansouri-Torshizi, Investigation of effects of newly synthesized Pt(II) complex against human serum albumin and leukemia cell line of K562. BMB Rep 43, 766 (2010)

    Article  CAS  Google Scholar 

  29. D. Chen, V. Milacic, M. Frezza, Q.P. Dou, Metal complexes, their cellular targets and potential for cancer therapy. Curr. Pharm. Des. 15, 777 (2009)

    Article  CAS  Google Scholar 

  30. B. Rosenberg, in Nucleic acid-metal ion interaction, vol. 1, ed. by T.G. Spiro (Wiley, New York, 1980), p. 1

  31. D. Lebwohl, R. Canetta, Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur. J. Cancer 34, 1522 (1998)

    Article  CAS  Google Scholar 

  32. U. Olszewski, G. Hamilton, A better platinum-based anticancer drug yet to come? Anticancer Agents Med. Chem. 10, 293 (2010)

    Article  CAS  Google Scholar 

  33. A. Divsalar, A.A. Saboury, H. Mansoori-Torshizi, F. Ahmad, Design, synthesis, and biological evaluation of a new palladium(II) complex: β-lactoglobulin and K562 as targets. J. Phys. Chem. B. 114, 3639 (2010)

    Article  CAS  Google Scholar 

  34. P.J. O’Dwyer, J.P. Stevenson, S.W. Johnson, in Cisplatin: Chemistry and biochemistry of a leading anticancer drug, ed. by B Lippert (Wiley, Weinheim, 1999), p. 31

  35. F.V. Rocha, C.V. Barra, A.V.G. Netto, A.E. Mauro, I.Z. Carlos, R.C.G. Frem, S.R. Ananias, M.B. Quilles, A. Stevanato, M.C. Rocha, 3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis spectral studies and antitumor activity. Eur. J. Med. Chem. 45, 1698 (2010)

    Article  CAS  Google Scholar 

  36. D. Wang, S.J. Lippard, Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4, 307 (2005)

    Article  CAS  Google Scholar 

  37. R. Tummala, P. Diegleman, S.A. Fiuza, L.A.E.D. Carvalho, M.P.M. Marquis, D.L. Kramer, L.P. Clark, S. Vujcic, C.W. Porter, L. Pendyala, Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells. Oncol. Rep. 24, 15 (2010)

    CAS  Google Scholar 

  38. E. Budzisz, U. Krajewska, M. Rozalski, Cytotoxic and proapoptotic effects of new Pd(II) and Pt(II)-complexes with 3-ethanimidoyl-2-methoxy-2H-1, 2-benzoxaphosphinin-4-ol-2-oxide. J. Pharm. 56, 473 (2004)

    CAS  Google Scholar 

  39. S. Hidaka, M. Tsuruoka, T. Funakoshi, H. Shimada, M. Kiyozumi, S. Kojima, Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats. Ren. Fail. 16, 337 (1994)

    Article  CAS  Google Scholar 

  40. H. Mansouri-Torshizi, M.I. Moghaddam, A. Divsalar, A.A. Saboury, 2,2′-Bipyridinebutyldithiocarbamatoplatinum(II) and palladium(II) complexes:synthesis, characterization, cytotoxicity, and rich DNA-binding studies. Bioorg. Med. Chem. 16, 9616 (2008)

    Article  CAS  Google Scholar 

  41. A. Divsalar, A.A. Saboury, L. Ahadi, E. Zemanatiyar, H. Mansouri-Torshizi, D. Ajloo, R.H. Sarma, Biological evaluation and interaction of a newly designed anti-cancer Pd(II) complex and human serum albumin. J. Biomol. Struct. Dyn. 29, 283 (2011)

    Article  CAS  Google Scholar 

  42. I. Kostova, Platinum complexes as anticancer agents. Recent Pat. Anti-Cancer Drug Discov. 1, 1 (2006)

    Article  CAS  Google Scholar 

  43. N.T. Abdel Ghani, A.M. Mansour, Novel Pd(II) and Pt(II) complexes of N,N-donor benzimidazole ligand: synthesis, spectral, electrochemical, DFT studies and evaluation of biological activity. Inorg. Chim. Acta. 373, 249 (2011)

    Article  CAS  Google Scholar 

  44. R.T. Dorr, A review of the modulation of cisplatin toxicities by chemoprotectants, in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, 2nd edn., ed. by H.M. Pinedo, J.H. Schornagel (Plenum Press, New York, 1996), p. 131

    Chapter  Google Scholar 

  45. H. Mansoori-Torshizi, M.I. Moghaddam, A. Divsalar, A.A. Saboury, Diimine platinum(I1) and palladium(I1) complexes of dithiocarbamate derivative as potential antitumor agents: synthesis, characterization, gytotoxicity, and detail DNA-binding studies. J. Biomol. Struct. Dyn. 26, 575 (2009)

    Article  Google Scholar 

  46. A.M. Florea, D. Büsselberg, Metals and metal compounds: occurrence, use, benefits and toxic cellular effects. Biometals 19, 419 (2006)

    Article  CAS  Google Scholar 

  47. R.Y. Tsang, T. Al-Fayea, H.J. Au, Cisplatin overdose: toxicities and management. Drug Saf. 32, 1109 (2009)

    Article  CAS  Google Scholar 

  48. E. Budzisz, U. Krajewska, M. Rozalski, A. Szulawska, M. Czyz, B. Nawrot, Biological evaluation of novel Pt(II) and Pd (II) complexes with pyrazole-containing ligands. Eur. J. Pharm. 502, 59 (2004)

    Article  CAS  Google Scholar 

  49. I. Brudzinska, Y. Mikata, M. Obata, C. Ohtsuki, S. Yanoa, Synthesis, structural characterization, and antitumor activity of palladium (II) complexes containing a sugar unit. Bioorg. Med. Chem. Lett. 14, 2533 (2004)

    Article  CAS  Google Scholar 

  50. L. Yan, X. Wang, Y. Wang, Y. Zhang, Y. Li, Z. Guo, Cytotoxic palladium(II) complexes of 8-aminoquinoline derivatives and the interaction with human serum albumin. J. Inorg. Biochem. 106, 46 (2012)

    Article  CAS  Google Scholar 

  51. A.C. Moro, A.E. Mauro, A.V.G. Netto, S.R.A. Nanias, M.B. Quilles, I.Z. Carlos, F.R. Pavan, C.Q.F. Leite, M. Horner, Antitumor and antimycobacterial activities of cyclopalladated complexes: X-ray structure of [Pd(C2, N-dmba)(Br)(tu)] (dmba = N,N-dimethylbenzylamine, tu = thiourea). Eur. J. Med. Chem. 44, 4611 (2009)

    Article  CAS  Google Scholar 

  52. K. Wang, J.F. Lu, R.C. Li, The events that occur when cisplatin en- counters cells. Coord. Chem. Rev. 151, 53 (1996)

    Article  CAS  Google Scholar 

  53. H. Mansoori-Torshizi, M. Islami-Moghaddam, A.A. Saboury, A microcalorimetry and spectroscopy study on the interaction of BSA with 2,2′ bipyridine octylglycinato palladium (II) nitrate. Acta Biochim. Biophys. Sin. 35, 886 (2003)

    CAS  Google Scholar 

  54. H. Mansouri-Torshiti, T.S. Srivastava, H.K. Perekh, M.P. Chitnis, Synthesis, spectroscopic, cytotoxic, and DNA binding studies of binuclear 2,2′-bipyridine-platinum(II) and -palladium(II) complexes of meso-alpha, alpha’-diaminoadipic and meso-alpha, alpha’-diaminosuberic acids. J. Inorg. Biochem. 45, 135 (1992)

    Article  Google Scholar 

  55. S.D. Schaefer, J.D. Post, L.G. Close, C.G. Wright, Ototoxicity of low- and moderate-dose cisplatin. Cancer 56, 1934 (1985)

    Article  CAS  Google Scholar 

  56. M.P. Goren, R.K. Wright, M.E. Horowitz, Cumulative renal tubular damage associated with cisplatin nephrotoxicity. Cancer Chemother. Pharmacol. 18, 69–73 (1986)

    Article  CAS  Google Scholar 

  57. D.S. Alberts, J.K. Noel, Cisplatin-associated neurotoxicity: can it be prevented? Anticancer Drugs 6, 369 (1995)

    Article  CAS  Google Scholar 

  58. J. Reedijk, Improved understanding in platinum antitumor chemistry. Chem. Commun. 7, 801–808 (1996)

    Article  Google Scholar 

  59. C.A. Rabik, M.E. Dolan, Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 33, 9 (2007)

    Article  CAS  Google Scholar 

  60. M. Gosland, B. Lum, J. Schimmelpfennig, J. Baker, M. Doukas, Insights into mechanisms of cisplatin resistance and potential for its clinical reversal. Pharmacotherapy 16, 16 (1996)

    CAS  Google Scholar 

  61. Z.H. Siddik, Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265 (2003)

    Article  CAS  Google Scholar 

  62. A.M. Montana, F.J. Bernal, J. Lorenzo, C. Farn´os, C. Batalla, M.J. Prieto, V. Moreno, F.X. Avil´es, J.M. Mesas, M.T. Alegre, Synthesis, characterization and antiproliferative studies of the enantiomers of cis-[(1,2-camphordiamine) dichloro]platinum(II) complexes. Bioorg. Med. Chem. 16, 1721 (2008)

    Article  CAS  Google Scholar 

  63. E. Wong, C.M. Giandomenico, Current status of platinum-based antitumor drugs. Chem. Rev. 99, 2451 (1999)

    Article  CAS  Google Scholar 

  64. J.M. Perez, A.I. Matesanz, A. Martin-Ambite, P. Navarro, C. Alonso, P. Souza, Synthesis and characterization of complexes of p-isopropyl benzaldehyde and methyl 2-pyridyl ketone thiosemicarbazones with Zn(II) and Cd(II) metallic centers. Cytotoxic activity and induction of apoptosis in Pam-ras cells. J. Inorg. Biochem. 75, 255 (1999)

    Article  CAS  Google Scholar 

  65. L.R. Kelland, S.Y. Sharp, C.F.O. O’Neill, F.I. Raynaud, P.J. Beale, I.R. Judson, Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance. J. Inorg. Biochem. 77, 111 (1999)

    Article  CAS  Google Scholar 

  66. S. Ahmad, A.A. Isab, S. Ali, Structural and mechanistic aspects of platinum anticancer agents. Transit. Met. Chem. 31, 1003 (2006)

    Article  CAS  Google Scholar 

  67. S. Ahmad, Platinum–DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes. Chem. Biodiv. 7, 543–566 (2010)

    Article  CAS  Google Scholar 

  68. Y. Jung, S.J. Lippard, Direct cellular responses to platinum-induced DNA damage. Chem. Rev. 107, 1387 (2007)

    Article  CAS  Google Scholar 

  69. D. Wong, S.J. Lippard, Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Disc. 4, 307 (2005)

    Article  CAS  Google Scholar 

  70. S.G. Chaney, S.L. Campbell, B. Temple, E. Bassett, Y. Wu, M. Faldu, Recognition and processing of platinum–DNA adducts. Crit. Rev. Oncol. Hematol. 53, 3 (2005)

    Article  Google Scholar 

  71. S. Nadeem, M. Bolte, S. Ahmad, T. Fazeelat, S.A. Tirmizi, M.K. Rauf, S.A. Sattar, S. Siddiq, A. Hameed, S.Z. Haider, Synthesis, crystal structures and antibacterial and antiproliferative activities in vitro of palladium(II) complexes of triphenylphosphine and thioamides. Inorg. Chim. Acta 363, 3261 (2010)

    Article  CAS  Google Scholar 

  72. I.H. Krakoff, in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, ed. by M. Nicoline (Springer, US, 1988), p. 351

  73. E.R. Jamieson, S.J. Lippard, Structure, recognition, and processing of cisplatin–DNA adducts. Chem. Rev. 99, 2467 (1999)

    Article  CAS  Google Scholar 

  74. P. Tyagi, P. Gahlot, R. Kakkar, Structural aspects of the anti-cancer drug oxaliplatin: a combinedtheoretical andexperimental study. Polyhedron 27, 3567 (2008)

    Article  CAS  Google Scholar 

  75. M.L. Chen, C.H. Fang, L.S. Liang, L.H. Dai, X.K. Wang, A meta-analysis of chemotherapy regimen fluorouracil/bleucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer. Surg. Oncol. 19, 38 (2010)

    Article  Google Scholar 

  76. Y. Ho, S.C. Au-Yeung, K.K. To, Platinum-based anticancer agents: innovative design strategies and biological perspectives. Med. Res. Rev. 23, 633 (2003)

    Article  CAS  Google Scholar 

  77. N.J. Wheate, J.G. Collins, Multi-nuclear platinum complexes as anti-cancer drugs. Coord. Chem. Rev. 241, 133 (2003)

    Article  CAS  Google Scholar 

  78. S. Carotti, G. Marcon, M. Marussich, T. Mazzei, L. Messori, E. Mini, P. Orioli, Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold (III) complex (GHAu). Chem. Biol. Interact. 125, 29 (2000)

    Article  CAS  Google Scholar 

  79. M. Baldini, M. Belicchi-Ferrari, F. Bisceglie, G. Pelosi, S. Pinelli, P. Tarasconi, Synthesis, characterisation and biological activity of three copper (II) complexes with a modified nitrogenous base: 5-formyluracil thiosemicarbazone. Inorg. Chem. 42, 2049 (2003)

    Article  CAS  Google Scholar 

  80. F. Dallavalle, F. Gaccioli, R. Franchi-Gazzola, M. Lanfranchi, L. Marchio, M.A. Pellinghelli, M.J. Tegoni, Synthesis, solution equilibria and antiproliferative activity of copper (II) aminomethyltriazole and aminomethylthioxotriazoline complexes. J. Inorg. Biochem. 92, 95 (2002)

    Article  CAS  Google Scholar 

  81. J.M. Perez, M.A. Fuertes, C. Alonso, C. Navarro-Ranninger, Current status of the development of trans-platinum antitumor drugs. Crit. Rev. Oncol. Hematol. 35, 109 (2000)

    Article  CAS  Google Scholar 

  82. L. Tušek-Božić, M. Juribasic, P. Traldi, V. Scarcia, A. Furlani, Synthesis, characterization and antitumor activity of palladium(II) complexes of monoethyl 8-quinolylmethylphosphonate. Polyhedron 27, 1317 (2008)

    Article  CAS  Google Scholar 

  83. A. Garoufis, S.K. Hadjikakou, N. Hadjiliadis, Palladium coordination compounds as anti-viral, anti-fungal, anti-microbial and anti-tumor agents. Coord. Chem. Rev. 253, 1384 (2009)

    Article  CAS  Google Scholar 

  84. A. Divsalar, A.A. Saboury, H. Mansouri-Torshizi, B. Hemmatnejad, Comparative and structural analysis of the interaction between β-lactoglobulin type A and B with a new anticancer component (2,2′- bipyridin n-hexyl dithiocarbamato Pd(II) nitrate). Bull. Korean Chem. Soc. 27, 1801 (2006)

    Article  CAS  Google Scholar 

  85. M. Saeidfar, H. Masouri-Torshizi, G.R. Behbehani, A. Divsalar, A.A. Saboury, A thermodynamic study of new designed complex of ethylendiamine 8-hydroxyquinolinato palladium(II) chloride with calf thymus DNA. Bull. Korean Chem. Soc. 30, 1951 (2009)

    Article  CAS  Google Scholar 

  86. K. Lee, T. Tashiro, M. Noji, Platinum and palladium complexes containing ethylenediamine derivatives as carrier ligands and their antitumor activity. Chem. Pharm. Bull. 43, 702 (1994)

    Article  Google Scholar 

  87. M.L. Gonzàles, J.M. Tercero, A. Matilla, J. Niclos-Gutierrez, M.T. Fernandez, M.C. Lopez, C. Alonso, S. Gonzalez, Cis-dichloro(alpha, omega-diamino carboxylate ethyl ester) palladium(II) as palladium(II) versus platinum(II) model anticancer drugs: synthesis, solution equilibria of their aqua, hydroxo, and/or chloro species, and in vitro/in vivo DNA-binding properties. Inorg. Chem. 36, 1806 (1997)

    Article  Google Scholar 

  88. M.A. Ali, A.H. Mirza, R.J. Butcher, M.T.H. Tarafder, T.B. Keat, A.M. Ali, Biological activity of palladium(II) and platinum(II) complexes of the acetone Schiff bases of S-methyl- and S-benzyldithiocarbazate and the X-ray crystal structure of the [Pd(asme)] (asme5anionic form of the two acetone Schiff base of S-methyldithiocarbazate) complex. J. Inorg. Biochem. 92, 141 (2002)

    Article  Google Scholar 

  89. A. Garoufis, S.K. Hadjikakou, N. Hadjiliadis, 46Pd the use of palladiumcomplexes in medicine, in Metallotherapeutic Drugs and Metal-Based Diagnostic Agents, ed. by M. Gielen, E.R.T. Tiekink (Wiley, Chichester, 2005), p. 399

    Chapter  Google Scholar 

  90. G. Zhao, H. Lin, S. Zhu, H. Sun, Y. Chen, Dinuclear palladium(II) complexes containing two monofunctional [Pd(en)(pyridine)Cl] units bridged by Se or S. Synthesis, characterization, cytotoxicity and kinetic studies of DNA-binding. J. Inorg. Biochem. 70, 219 (1998)

    Article  CAS  Google Scholar 

  91. H. Mansouri-Torshizi, M. Islami-Moghaddam, A.A. Saboury, A microcalorimetry and spectroscopy study on the interaction of BSA with 2,2′-bipyridine octylglycinato palladium (II) nitrate. Acta Biochem. Biophys. Sin. 35, 886 (2003)

    Google Scholar 

  92. G. Rezaei Behbehani, A. Divsalar, A.A. Saboury, M.J. Bagheri, A thermodynamic study on the binding of human serum albumin with new synthesized anti cancer Pd(II) complex. J. Sol. Chem. 37, 1785 (2008)

    Article  CAS  Google Scholar 

  93. S. Arounaguiri, B.G. Maiya, “Electro-photo switch” and “molecular light switch” devices based on ruthenium (II) complexes of modified dipyridophenazine ligands: modulation of the photochemical function through ligand design. Inorg. Chem. 38, 842 (1999)

    Article  CAS  Google Scholar 

  94. J.L. Butour, S. Wimmer, F. Wimme, P. Castan, Palladium(II) compounds with potential antitumor properties and their platinum analogues: a comparative study of the reaction of some orotic acid derivatives with DNA in vitro. Chem. Biol. Interact. 104, 165 (1997)

    Article  CAS  Google Scholar 

  95. S.E. Livingstone, Cancer Forum. 15, 144 (1978)

    CAS  Google Scholar 

  96. M. Das, S.E. Livingstone, Cytotoxic action of some transition metal chelates of Schiff bases derived from S-methyldithiocarbazate. Brit. J. Cancer. 37, 466 (1978)

    Article  CAS  Google Scholar 

  97. A. Shoukry, T. Rau, M. Shoukry, R. van Eldik, Kinetics and mechanisms of the ligand substitution reactions of bis(amine)(cyclobutane-1,1-dicarboxylato) palladium(II). J. Chem. Soc., Dalton Trans. 18, 3105 (1998)

    Article  Google Scholar 

  98. G. Zhao, H. Lin, Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment. Curr. Med. Chem. AntiCancer Agents 5, 137 (2005)

    Article  CAS  Google Scholar 

  99. J. Kuduk-Jaworska, A. Puszko, M. Kubiak, M. Pełczynska, Synthesis, structural, physico-chemical and biological properties of new palladium(II) complexes with 2,6-dimethyl-4-nitropyridine. J. Inorg. Biochem. 98, 1447 (2004)

    Article  CAS  Google Scholar 

  100. D. Kovala-Demertzi, A. Bocarelli, M.A. Demertzis, M. Coluccia, In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes. Chemotherapy 53, 148 (2007)

    Article  CAS  Google Scholar 

  101. M. Juribašić, K. Molčanov, B. Kojić-Prodić, L. Bellotto, M. Kralj, F. Zani, L. Tušek-Božić, Palladium (II) complexes of quinolinylaminophosphonates: synthesis, structural characterization, antitumor and antimicrobial activity. J. Inorg. Biochem. 105, 867 (2011)

    Article  CAS  Google Scholar 

  102. M. Islami-Moghaddam, H. Mansouri-Torshizi, A. Divsalar, A.A. Saboury, Synthesis, characterization, cytotoxic and DNA binding studies of diimine platinum (II) and palladium(II) complexes of short hydrocarbon chain ethyldithiocarbamate ligand. J. Iran. Chem. Soc. 6, 552 (2009)

    Article  CAS  Google Scholar 

  103. E. Bermejo, R. Carballa, A. Castineiras, R. Dominguez, A.E. Liberta, C. Maichelle-Mössmer, M.M. Salberg, D.X. West, Synthesis, structural characteristics and biological activities of complexes of ZnII, CdII, HgII, PdII, and PtII with 2-acetylpyridine 4-methylthiosemicarbazone. Eur. J. Inorg. Chem. 6, 965 (1999)

    Article  Google Scholar 

  104. A.G. Quiroga, J.M. Perez, I. Lopez-Solera, J.R. Masaguer, A. Luque, P. Roman, A.C. Edwaeds, C. Alonso, C. Navarro-Ranninger, Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p-isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA. J. Med. Chem. 41, 1399 (1998)

    Article  CAS  Google Scholar 

  105. T.V. Polyanskaya, I. Kazhdanb, M.D. Motleya, J.A. Walmsley, Synthesis, characterization and cytotoxicity studies of palladium (II)-proflavine complexes. J. Inorg. Biochem. 104, 1205 (2010)

    Article  CAS  Google Scholar 

  106. A.S. Abu-Surrah, H.H. Al-Sa’doni, M.Y. Abdalla, Palladium based chemotherapeutic agents. Routes towards complexes with good antitumor activity. Cancer Ther. 6, 1 (2008)

    CAS  Google Scholar 

  107. DS Gill, in Platinum coordination complexes in cancer chemotherapy, ed. by M.P. Hacker, E.B. Douple, I.H. Krako (Nijho, Boston, 1984), pp. 267–278

  108. A.S. Abu-Surrah, M. Kettunen, Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin. Curr. Med. Chem. 13, 1337 (2006)

    Article  CAS  Google Scholar 

  109. S. Ray, R. Mohan, J.K. Singh, M.K. Samantaray, M.M. Shaikh, D. Panda, P. Ghosh, Anticancer and antimicrobial metallopharmaceutical agents based on palladium, gold, and silver N-heterocyclic carbene complexes. J. Am. Chem. Soc. 129, 15042 (2007)

    Article  CAS  Google Scholar 

  110. T. Storr, K.H. Thompson, C. Orvig, Design of targeting ligands in medicinal inorganic chemistry. Chem. Soc. Rev. 35, 534 (2006)

    Article  CAS  Google Scholar 

  111. J.M. Vujic, M. Cvijovic, G.N. Kaluderovic, M. Milovanovic, B.B. Zmejkovskic, V. Volarevic, N. Arsenijevic, T.R. Sabo, S.R. Trifunovic, Palladium(II) complexes with R2edda derived ligands. Part IV. O,O′-dialkyl esters of (S,S)-ethylenediamine-N,N′-di-2-(4-methyl)-pentanoic acid dihydrochloride and their palladium(II) complexes: synthesis, characterization and in vitro antitumoral activity against chronic lymphocytic leukemia (CLL) cells. Eur. J. Med. Chem. 45, 3601 (2010)

    Article  CAS  Google Scholar 

  112. G. Faraglia, D. Fregona, S. Sitran, L. Giovagnini, C. Marzano, F. Baccichetti, U. Casellato, R. Graziani, Platinum(II) and palladium(II) complexes with dithiocarbamates and amines: synthesis, characterization and cell assay. J. Inorg. Biochem. 83, 31 (2001)

    Article  CAS  Google Scholar 

  113. L. Giovagnini, L. Ronconi, D. Aldinucci, D. Lorenzon, S. Sitran, D. Fregona, Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes. J. Med. Chem. 48, 1588 (2005)

    Article  CAS  Google Scholar 

  114. G.B. Onoa, G. Cervantes, V. Moreno, M.J. Prieto, Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy. Nucl. Acids Res. 26, 1473 (1998)

    Article  CAS  Google Scholar 

  115. R.A. De Souza, A. Stevanato, O. Treu-Filho, A.V.G. Netto, A.E. Mauro, E.E. Castellano, I.Z. Carlos, F. Pavan, C.Q.F. Leite, Antimycobacterial and antitumor activities of palladium(II) complexes containing isonicotinamide (isn): X-ray structure of trans-[Pd(N3)2(isn)2]. Eur. J. Med. Chem. 45, 4863 (2010)

    Article  CAS  Google Scholar 

  116. A.L. Mattesanze, J.M. Perez, P. Navarro, J.M. Moeno, E. Colacio, P. Souza, Synthesis and characterization of novel palladium(II) complexes of bis(thiosemicarbazone). Structure, cytotoxic activity and DNA binding of Pd(II)-benzyl bis(thiosemicarbazonate). J. Inorg. Biochem. 76, 29 (1999)

    Article  Google Scholar 

  117. Z. Lakovidou, A. Papageorgiou, M.A. Demertzis, E. Mioglou, D. Mourelatos, A. Kotsis, P.N. Yadav, D. Kovala-Demertzi, Platinum(II) and palladium(II) complexes with 2-acetylpyridine thiosemicarbazone: cytogenetic and antineoplastic effects. Anticancer Drugs 12, 65 (2001)

    Article  CAS  Google Scholar 

  118. L. Giovagnini, C. Marzano, F. Bettio, D. Fregona, Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents. J. Inorg. Biochem. 99, 2139 (2005)

    Article  CAS  Google Scholar 

  119. V. Alverdi, L. Giovagnini, C. Marzano, R. Seraglia, F. Bettio, S. Sitran, R. Graziani, D. Fregona, Characterization studies and cytotoxicity assays of Pt(II) and Pd(II) dithiocarbamate complexes by means of FT-IR, NMR spectroscopy and mass spectrometry. J. Inorg. Biochem. 98, 1117 (2004)

    Article  CAS  Google Scholar 

  120. F. Shaheen, A. Badshah, M. Gielen, M.L. Dusek, K. Fejfarova, D. de Vos, B. Mirza, Synthesis, characterization, antibacterial and cytotoxic activity of new palladium(II) complexes with dithiocarbamate ligands: X-ray structure of bis(dibenzyl-1-S:S’-dithiocarbamato) Pd(II). J. Organometal. Chem. 692, 3019 (2007)

    Article  CAS  Google Scholar 

  121. H. Mansouri-Torshizi, M. Saeidifar, F. Khosravi, A. Divsalar, A.A. Saboury, F. Hassani, DNA binding and antitumor activity of α-diimineplatinum(II) and palladium(II) dithiocarbamate complexes. Bioinorg. Chem. Appl. 11, 506 (2011)

    Google Scholar 

  122. H. Mansouri-Torshizi, M. Saeidifar, A. Divsalar, A.A. Saboury, Study on interaction of DNA from calf thymus with 1,10-phenanthrolinehexyldithiocarbamatopalladium (II) nitrate as potential antitumor agent. J. Biomol. Struct. Dyn. 28, 805 (2011)

    Article  CAS  Google Scholar 

  123. H. Mansouri-Torshizi, M. Eslami-Moghadam, A. Divsalar, A.A. Saboury, DNA-binding studies of some potential antitumor 2,2′-bipyridine Pt(II)/Pd(II) complexes of piperidinedithiocarbamate. Their synthesis, spectroscopy and cytotoxicity. Acta. Chim. Slov. 58, 811 (2011)

    CAS  Google Scholar 

  124. H. Mansouri-Torshizi, M. Saeidifara, A. Divsalar, A.A. Saboury, Interaction studies between a 1,10-phenanthroline adduct of palladium(II) dithiocarbamate anti-tumor complex and calf thymus DNA. A synthesis spectral and in vitro study. Spectrochim. Acta, Part A 77, 312 (2010)

    Article  CAS  Google Scholar 

  125. D. Montagner, C. Marzano, V. Gandin, Synthesis, characterization and cytotoxic activity of palladium (II) dithiocarbamate complexes with α, ω-diamines. Inorg. Chim. Acta 376, 574 (2011)

    Article  CAS  Google Scholar 

  126. N. Gligorijevic, T. Todorovic, S. Radulovic, D. Sladic, N. Filipovic, D. GoCevac, D. Jeremic, K. AnCelkovic, Synthesis and characterization of new Pt(II) and Pd(II) complexes with 2-quinolinecarboxaldehyde selenosemicarbazone: cytotoxic activity evaluation of Cd(II), Zn(II), Ni(II), Pt(II) and Pd(II) complexes with heteroaromatic selenosemicarbazones. Eur. J. Med. Chem. 44, 1623 (2009)

    Article  CAS  Google Scholar 

  127. D. Kovala-Demertzi, A. Galani, J.R. Miller, C.S. Frampton, M.A. Demertzis, Synthesis, structure, spectroscopic studies and cytotoxic effect of novel palladium (II) complexes with 2-formylpyridine-4-nethyl-thiosemicarbazone: potential antitumor agents. Polyhedron 52, 1096 (2012)

    Article  CAS  Google Scholar 

  128. H.A. El-Boraey, Coordination behavior of tetraaza [N4] ligand towards Co(II), Ni(II), Cu(II), Cu(I) and Pd(II) complexes: synthesis, spectroscopic characterization and anticancer activity. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 97, 255 (2012)

    Article  CAS  Google Scholar 

  129. K.H. Puthraya, T.S. Srivastava, A.J. Amonkar, M.K. Adwankar, M.P. Chitnis, Some potential anticancer palladium(II) complexes of 2,2′-bipyridine and amino acids. J. Inorg. Biochem. 26, 45 (1986)

    Article  CAS  Google Scholar 

  130. N.T. Abdel Ghani, A.M. Mansour, Novel palladium(II) and platinum(II) complexes with 1H-benzimidazol-2-ylmethyl-N-(4-bromo-phenyl)-amine: structural studies and anticancer activity. Eur. J. Med. Chem. 47, 399 (2012)

    Article  CAS  Google Scholar 

  131. L. Tušek-Božić, A. Furlani, V. Scarcia, E. De Clercq, J. Balzarini, Spectroscopic and biological properties of palladium(II) complexes of ethyl 2-quinolylmethylphosphonate. J. Inorg. Biochem. 72, 201 (1998)

    Article  Google Scholar 

  132. U. Kalinowska-Lis, L. Szmigiero, K. Studzian, J. Ochocki, Cytotoxic activity and chemical reactivity of cis-platinum(II) and trans-palladium(II) complexes with diethyl (pyridinylmethyl) phosphates. Eur. J. Med. Chem. 44, 660 (2009)

    Article  CAS  Google Scholar 

  133. C.Y. Shi, E.J. Gao, S. Ma, M.L. Wang, Q.T. Liu, Synthesis, crystal structure, DNA-binding and cytotoxicity in vitro of novel cis-Pt(II) and trans-Pd(II) pyridine carboxamide complexes. Bioorg. Med. Chem. Lett. 20, 7250 (2010)

    Article  CAS  Google Scholar 

  134. C. Icsel, V.T. Yilmaz, F. Ari, E. Ulukaya, W.T.A. Harrison, Trans-dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl) pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies. Eur. J. Med. Chem. 60, 386 (2013)

    Article  CAS  Google Scholar 

  135. X. Riera, V. Moreno, C.J. Ciudad, V. Noe, M. Font-Bard´ıa, X. Solans, Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity. Bioinorg. Chem. App. 2007, 1–15 (2007)

    Article  CAS  Google Scholar 

  136. M. Al-Noaimi, A.S. Abu-Surrah, L. Tahtamouni, Palladium(II) complexes incorporating phenylazo arylmethine ancillary ligands: synthesis, spectral and antitumor activity. Arab. J. Chem. (2012). doi:10.1016/j.arabjc.2012.03.009 (in press)

  137. N. Malesevic, T. Srdic, S. Radulovic, D. Sladic, V. Radulovic, I. Brceski, K. Andelkovic, Synthesis and characterization of a novel Pd (II) complex with the condensation product of 2-(diphenylphosphino) benzaldehyde and ethyl hydrazinoacetate. Cytotoxic activity of the synthesized complex and related Pd(II) and Pt(II) complexes. J. Inorg. Biochem. 100, 1811 (2006)

    Article  CAS  Google Scholar 

  138. A.F. Elhusseiny, H.H.A.M. Hassan, Antimicrobial and antitumor activity of platinum and palladium complexes of novel spherical aramides nanoparticles containing flexibilizing linkages: structure–property relationship. Spectrochim. Acta Part A: Mol. Biomol. Spectrosc. 103, 232 (2013)

    Article  CAS  Google Scholar 

  139. J. Vázquez, S. Bernès, P. Sharma, J. Pérez, G. Hernández, A. Tovar, U. Peña, R. Gutiérrez, Synthesis, characterization and anticancer activity of new chiral Pd(II)-complexes derived from unsymmetrical adiimine ligands. Polyhedron 30, 2514 (2011)

    Article  CAS  Google Scholar 

  140. B.B. Zmejkovskic, G.N. Kaluderovic, S. Gomez-Ruiz, Z. Zizak, D. Steinborn, H. Schmidt, R. Paschke, Z.D. Juranic, T.J. Sabo, Palladium (II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium (II) complexes. Eur. J. Med. Chem. 44, 3452 (2009)

    Article  CAS  Google Scholar 

  141. K. Karami, M. Hosseini kharat, H. Sadeghi-Aliabadi, J. Lipkowski, M. Mirian, Dinuclear bridged biphosphinic and mononuclear cyclopalladated complexes of benzylamines: synthesis, structural characterization and antitumor activity. Polyhedron 50, 187 (2012)

    Article  CAS  Google Scholar 

  142. Z.D. Matović, E. Mrkalić, G. Bogdanović, V. Kojić, A. Meetsma, R. Jelić, Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium (II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation. J. Inorg. Biochem. 121, 134 (2013)

    Article  CAS  Google Scholar 

  143. J. Li, L. Zhang, L. Wang, F. Zhang, X. Li, Synthesis, characterization and cytotoxicity of mixed-ligand complexes of palladium (II) with aromatic diimine and 4-toluenesulfonyl-l-amino acid dianion. Eur. J. Med. Chem. 45, 5337 (2010)

    Article  CAS  Google Scholar 

  144. P. Štarha, Z. Trávnícek, I. Popa, Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands. J. Inorg. Biochem. 103, 978 (2009)

    Article  CAS  Google Scholar 

  145. P. Štarha, I. Popa, Z. Trávnícek, Palladium(II) oxalato complexes involving N6-(benzyl)-9-isopropyladenine-based N-donor carrier ligands: synthesis, general properties,1H,13C and 15N{1H} NMR characterization and in vitro cytotoxicity. Inorg. Chim. Acta 363, 1469 (2010)

    Article  CAS  Google Scholar 

  146. E.J. Gao, K.H. Wang, M.C. Zhu, L. Liu, Hairpin-shaped tetranuclear palladium(II) complex: synthesis, crystal structure, DNA binding and cytotoxicity activity studies. Eur. J. Med. Chem. 45, 2784 (2010)

    Article  CAS  Google Scholar 

  147. E.J. Gao, L. Wang, M.C. Zhu, L. Liu, W.Z. Zhang, Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of the complexes [M(dmphen)(CO3)].H2O[M = Pt(II), Pd(II)]. Eur. J. Med. Chem. 45, 311 (2010)

    Article  CAS  Google Scholar 

  148. C. Abbehausen, S.F. Sucena, M. Lancellotti, T.A. Heinrich, E.P. Abrão, C.M. Costa Neto, A.L.B. Formiga, P.P. Corbi, Synthesis, spectroscopic characterization, DFT studies, and antibacterial and antitumor activities of a novel water soluble Pd(II) complex with L-alliin. J. Mol. Struct. 1035, 421 (2013)

    Article  CAS  Google Scholar 

  149. E. Ulukaya, F. Ari, K. Dimas, I.E. Ikitimur, E.L. Guney, V.T. Yilmaz, Anti-cancer activity of a novel palladium (II) complex on human breast cancer cells in vitro and in vivo. Eur. J. Med. Chem. 46, 4957 (2011)

    Article  CAS  Google Scholar 

  150. S.V. Voitekhovich, T.V. Serebryanskaya, A.S. Lyakhov, P.N. Gaponik, O.A. Ivashkevich, Copper (II), palladium (II) and platinum (II) chloride complexes with 5-amino-2-tert-butyltetrazole: synthesis, characterization and cytotoxicity. Polyhedron 28, 3614 (2009)

    Article  CAS  Google Scholar 

  151. K. Akdi, R.A. Vilaplana, S. Kamah, J.A.R. Navarro, J.M. Salas, F. Gonzalez-Vılchez, Study of the biological effects and DNA damage exerted by a new dipalladium-Hmtpo complex on human cancer cells. J. Inorg. Biochem. 90, 51 (2002)

    Article  CAS  Google Scholar 

  152. G. Zhao, H. Lin, P. Yu, H. Sun, S. Zhu, X. Su, Ethylenediamine–palladium(II) complexes with pyridine and its derivatives: synthesis, molecular structure and initial antitumor studies. J. Inorg. Biochem. 73, 145 (1999)

    Article  CAS  Google Scholar 

  153. W.M. Motswainyana, M.O. Onani, A.M. Madiehe, Bis(ferrocenylimine) palladium(II) and platinum(II) complexes: synthesis, molecular structures and evaluation as antitumor agents. Polyhedron 41, 44 (2012)

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The financial support of Research Council of the Kharazmi University is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adeleh Divsalar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jahromi, E.Z., Divsalar, A., Saboury, A.A. et al. Palladium complexes: new candidates for anti-cancer drugs. J IRAN CHEM SOC 13, 967–989 (2016). https://doi.org/10.1007/s13738-015-0804-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13738-015-0804-8

Keywords

Navigation